Education
About Us
Working with TipRanks
Follow Us
Doseology Sciences, Inc. (TSE:MOOD)
:MOOD
Total Valuation
Doseology Sciences has a market cap or net worth of C$5.13M. The enterprise value is C$902.77K.
Market CapC$5.13M
Enterprise ValueC$902.77K
Share Statistics
Doseology Sciences has 8,011,621 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,011,621
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Doseology Sciences’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -33.74%.
Return on Equity (ROE)-0.32
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-33.74%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.03
Inventory Turnover1.39
Valuation Ratios
The current PE Ratio of Doseology Sciences is ―. Doseology Sciences’s PEG ratio is -0.49.
PE Ratio―
PS Ratio113.73
PB Ratio3.46
Price to Fair Value3.46
Price to FCF-14.14
Price to Operating Cash Flow-24.69
PEG Ratio-0.49
Income Statement
In the last 12 months, Doseology Sciences had revenue of 42.56K and earned -447.79K in profits. Earnings per share was -0.10.
Revenue42.56K
Gross Profit18.89K
Operating Income-471.61K
Pretax Income-447.79K
Net Income-447.79K
EBITDA-471.61K
Earnings Per Share (EPS)-0.10
Cash Flow
In the last 12 months, operating cash flow was -230.85K and capital expenditures 0.00, giving a free cash flow of -230.84K billion.
Operating Cash Flow-230.85K
Free Cash Flow-230.84K
Free Cash Flow per Share-0.03
Dividends & Yields
Doseology Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-4.33
52-Week Price Change300.00%
50-Day Moving Average0.53
200-Day Moving Average0.57
Relative Strength Index (RSI)49.49
Average Volume (3m)1.79K
Important Dates
Doseology Sciences upcoming earnings date is Mar 2, 2026, After Close (Confirmed).
Last Earnings DateNov 25, 2025
Next Earnings DateMar 2, 2026
Ex-Dividend Date―
Financial Position
Doseology Sciences as a current ratio of 15.85, with Debt / Equity ratio of 0.00%
Current Ratio15.85
Quick Ratio15.67
Debt to Market Cap0.00
Net Debt to EBITDA3.03
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Doseology Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Doseology Sciences EV to EBITDA ratio is -7.23, with an EV/FCF ratio of -9.96.
EV to Sales80.14
EV to EBITDA-7.23
EV to Free Cash Flow-9.96
EV to Operating Cash Flow-9.96
Balance Sheet
Doseology Sciences has C$1.43M in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$1.43M billion.
Cash & Marketable SecuritiesC$1.43M
Total DebtC$0.00
Net CashC$1.43M
Net Cash Per ShareC$0.18
Tangible Book Value Per ShareC$0.30
Margins
Gross margin is 46.63%, with operating margin of -1108.20%, and net profit margin of -1052.23%.
Gross Margin46.63%
Operating Margin-1108.20%
Pretax Margin-1052.23%
Net Profit Margin-1052.23%
EBITDA Margin-1108.20%
EBIT Margin-1108.20%
Analyst Forecast
The average price target for Doseology Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-50.89%
EPS Growth Forecast-32.33%